Monoclonal antibody appears effective and safe in asthma phase IIa trial
Tuesday, May 21, 2013 - 21:00
in Health & Medicine
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.